Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR
出版年份 2021 全文链接
标题
Harmaline isolated from
Peganum harmala
suppresses growth of esophageal squamous cell carcinoma through targeting
mTOR
作者
关键词
-
出版物
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-09-21
DOI
10.1002/ptr.7289
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology : Reproducibility of natural product research
- (2020) Angelo A. Izzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
- (2020) Xueyin Zu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Kidney Pathophysiology, Toxicology, and Drug-Induced Injury in Drug Development
- (2019) Zaher A. Radi INTERNATIONAL JOURNAL OF TOXICOLOGY
- Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells
- (2019) Xueyin Zu et al. PHYTOTHERAPY RESEARCH
- Scutellarin suppresses patient-derived xenograft tumor growth by directly targeting AKT in esophageal squamous cell carcinoma
- (2019) Feifei Liu et al. Cancer Prevention Research
- mTOR: Role in cancer, metastasis and drug resistance
- (2019) Avaniyapuram Kannan Murugan SEMINARS IN CANCER BIOLOGY
- Potentiation of morphine-induced antinociception by harmaline: involvement of μ-opioid and ventral tegmental area NMDA receptors
- (2019) Sakineh Alijanpour et al. PSYCHOPHARMACOLOGY
- Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
- (2018) Manoj Kumar Kashyap et al. Molecular Cancer
- Effects of a Peganum harmala (Zygophyllaceae) preparation for root canal disinfection
- (2018) Mehdi Tabrizizadeh et al. PHYTOTHERAPY RESEARCH
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
- (2016) Thomas Powles et al. EUROPEAN UROLOGY
- Harmaline-induced amnesia: Possible role of the amygdala dopaminergic system
- (2016) M. Nasehi et al. NEUROSCIENCE
- mTORC1 and mTORC2 in cancer and the tumor microenvironment
- (2016) L C Kim et al. ONCOGENE
- Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma
- (2015) Shau-Hsuan Li et al. SURGERY
- Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma
- (2015) Jianjun Lu et al. Biomed Research International
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Esophageal Carcinoma
- (2014) Anil K. Rustgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
- (2013) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma
- (2012) A Naing et al. BRITISH JOURNAL OF CANCER
- Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
- (2012) K Hirashima et al. BRITISH JOURNAL OF CANCER
- Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma
- (2012) Seok-Hyung Kim et al. HUMAN PATHOLOGY
- Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
- (2010) Sara M. Johnson et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- A comprehensive map of the mTOR signaling network
- (2010) Etienne Caron et al. Molecular Systems Biology
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now